In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 9, 2003, Pages 3008-3011

  Goldstein, Ellie J C ^a,b,c   Citron, Diane M ^a   Merriam, C Vreni ^a   Warren, Yumi A ^a   Tyrrell, Kerin L ^a   Fernandez, Helen T ^a  

^a R M ALDEN RESEARCH LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (6 AMINO 3,5 DIFLUORO 2 PYRIDYL) 8 CHLORO 6 FLUORO 1,4 DIHYDRO 7 (3 HYDROXY 1 AZETIDINYL) 4 OXO 3 QUINOLINECARBOXYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME; GATIFLOXACIN; LEVOFLOXACIN; METICILLIN; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG ACTIVITY; HAEMOPHILUS INFLUENZAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PREVOTELLA; PRIORITY JOURNAL; SINUSITIS; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; BACTERIA, AEROBIC; BACTERIA, ANAEROBIC; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; PARANASAL SINUSES; QUINOLONES; SINUSITIS;

EID: 0041922531     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.9.3008-3011.2003     Document Type: Article

References (18)

1. Brook, I. 2002. Anaerobic bacteria in upper respiratory tract and other head and neck infections. Ann. Otol. Rhinol. Laryngol. 111:430-440.
2. Brueggemann, A. B., S. L. Coffman, P. Rhomberg, H. Huynh, L. Almer, A. Nilius, R. Flamm, and G. V. Doern. 2002. Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995. Antimicrob. Agents Chemother. 46:680-688.
3. Finegold, S. M., M. J. Flynn, F. V. Rose, H. Jousimies-Somer, C. Jakielaszeic, M. McTeague, H. M. Wexler, E. Berkowitz, and B. Wynne. 2002. Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults. Clin. Infect. Dis. 35:428-433.
4. Goldstein, E. J. C., and S. M. Garabedian-Ruffalo. 2002. Widespread use of fluoroquinolones versus emerging resistance of pneumococci. Clin. Infect. Dis. 35:1505-1511.
5. Goldstein, E. J. C., D. M. Citron, and C. V. Merriam. 1999. Comparative in vitro activities of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitis. Antimicrob. Agents Chemother. 43:705-707.
6. Greenberg, D., D. P. Speert, E. Mahenthiralingam, D. A. Henry, L. E. Campbell, D. W. Scheifele, and the CPS/LCDC IMPACT Monitoring Network. 2002. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae invasive clones in Canada. J. Clin. Microbiol. 40:68-74.
7. Grollier, G., G. Le Moal, R. Robert, C. Bernard, and J. M. Klossek. 2000. Role des bacteries anaerobies strictes dans les sinusitis. Med. Mal. Infect. 30(Suppl. 2):109-113.
8. Ho, P. L., R. W. H. Yung, D. N. C. Tsang, T. L. Que, M. Ho, W. H. Seto, T. K. Ng, W. C. Yam, and W. W. S. Ng. 2001. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicenter study in 2000. J. Antimicrob. Chemother. 48:659-665.
9. Jousimies-Somer, H. R., P. Summanen, D. M. Citron, E. J. Baron, H. M. Wexler, and S. M. Finegold. 2002. Wadsworth-KTL anaerobic bacteriology manual, 6th ed. Star Publishing Company, Belmont, Calif.
10. Jousimies-Somer, H. R., S. Savolainen, and J. S. Ylikoski. 1988. Bacteriological findings of acute maxillary sinusitis in young adults. J. Clin. Microbiol. 26:1919-1925.
11. Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken. 1999. Manual of clinical microbiology, 7th ed. ASM Press, Washington, D.C.
12. National Committee for Clinical Laboratory Standards. 2001. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 5th ed. Approved standard. NCCLS publication no. M11-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. National Committee for Clinical Laboratory Standards. 2000. Method for dilution antimicrobial susceptibility testing for bacteria that grow aerobically: approved standard, 5th ed. NCCLS publication no. M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Sinus and Allergy Health Partnership. 2000. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol. Head Neck Surg. 123(Suppl. 1, Part 2):S1-S32.
15. Thornsberry, C., P. Ogilvie, H. P. Holley, Jr., and D. F. Sahm. 1999. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study. Antimicrob. Agents Chemother. 43:2616-2623.
16. Tomioka, H., K. Sato, H. Kajitani, T. Akaki, and S. Shishido. 2000. Comparative antimicrobial activities of the newly synthesized quinolone WQ3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrob. Agents Chemother. 44:283-286.
17. Urban, C., N. Rahman, X. Zhao, N. Mariano, S. Segal-Maurer, K. Drlica, and J. J. Rahal. 2001. Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy. J. Infect. Dis. 184:794-798.
18. U.S. Department of Health and Human Services. 1987. National health survey. Prevalence of selected chronic conditions. United States, 1983-1985. U.S. Department of Health and Human Services, Hyattsville, Md.